Evaluation of the Effect of Pulmonary Rehabilitation in COVID-19 Patients

Not Applicable

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20191125045496N3
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

COVID-19 Patients aged 35 to 75 years old
No history of chronic diseases such as heart, orthopedic and motor disorders, diabetes, multiple sclerosis and cancer that interfere with the rehabilitation program
The ability to use the technology or caregiver that made it possible for him to be quarantined

Exclusion Criteria

Asthma and any underlying lung disease are neuromuscular diseases that affect lung function.
Lack of patient cooperation and lack of motivation
Taking antidepressants and anti-anxiety drugs two months before the intervention

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life. Timepoint: At baseline (before intervention) and 6 weeks after intervention. Method of measurement: Short Form Quality of Life Questionnaire (SF-36).;Anxiety and Depression scale. Timepoint: At baseline (before intervention) and 6 weeks after intervention. Method of measurement: Hospital Anxiety Depression scale (HADS).;Fatigue scale. Timepoint: At baseline (before intervention) and 6 weeks after intervention. Method of measurement: Osmens Multidimensional Fatigue Inventory Questionnaire.